BioDelivery Sciences Appoints Industry Vet as New GC
The pain management and addiction pharmaceutical company announced that James Vollins is taking over as general counsel, chief compliance officer and corporate secretary at the Raleigh, North Carolina-based company.
November 05, 2018 at 02:49 PM
3 minute read
James Vollins, GC, chief compliance officer and corporate secretary at BioDelivery Sciences International
Pain management and addiction pharmaceutical company BioDelivery Sciences International Inc. announced that industry veteran James “Jim” Vollins is taking over as general counsel.
Vollins' appointment as GC, chief compliance officer and corporate secretary is part of an executive leadership shakeup that includes the retirement of the Raleigh, North Carolina-based company's chief financial officer and corporate secretary next year and the president's additional role of chief commercial officer.
➤➤ Get in-house news and commentary straight to your inbox with Inside Track. Sign up here.
Vollins brings more than 12 years of experience working with pharmaceutical and biotechnology companies to BDSI. Most recently, he served as vice president, GC, director of compliance and secretary at international biotech company Bio Products Laboratory, according to his LinkedIn profile.
Prior to that, he held in-house roles at pharma giant Pfizer Inc. and after that at Spanish blood plasma-based products company Grifols. Before going in-house, Vollins was in private practice at Ulmer & Berne and later Squire, Sanders & Dempsey (now Squire Patton Boggs), where he represented corporate clients in diverse commercial matters, including compliance with health care fraud and abuse laws, according to LinkedIn.
In his new role, Vollins succeeds Dan Darnley, who left BDSI last May to become VP and chief intellectual property counsel at Waltham, Massachusetts-based Radius Health Inc., according to Darnley's LinkedIn profile.
Vollins said in an interview Monday that the main priority for his legal department of one is to help BDSI grow in a compliant and appropriate manner and achieve its financial and other strategic objectives.
“BDSI is at an exciting phase of its development with the commercialization of its leading product, Belbuca,” Vollins said. “This is a great opportunity to work for a company that has great growth potential.”
BDSI has two main products: Belbuca, a buprenorphine buccal film to treat chronic pain, and Bunavail, a combination of buprenorphine and naloxone buccal film to treat opioid dependence.
“We are delighted to welcome Jim to our leadership team during this exciting time of rapid company growth,” BDSI CEO Herm Cukier said in a statement announcing Vollins' appointment. “His extensive and wide ranging legal, compliance, and corporate governance experience as part of public companies will further enhance our ability to successfully capitalize on the continued potential of Belbuca growth and beyond.”
Vollins earned his degree from Case Western Reserve University School of Law.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View All![FTC Launches Inquiry of Single-Family Rental Home 'Mega Investors,' Issues PBM Report FTC Launches Inquiry of Single-Family Rental Home 'Mega Investors,' Issues PBM Report](https://images.law.com/cdn-cgi/image/format=auto,fit=contain/https://images.law.com/corpcounsel/contrib/content/uploads/sites/389/2024/08/US-Federal-Trade-Commission-Building-2022-009-767x633.jpg)
FTC Launches Inquiry of Single-Family Rental Home 'Mega Investors,' Issues PBM Report
5 minute read![Scripture-Quoting Employee Sues Company for Supporting LGBTQ Pride Scripture-Quoting Employee Sues Company for Supporting LGBTQ Pride](https://images.law.com/cdn-cgi/image/format=auto,fit=contain/https://k2-prod-alm.s3.us-east-1.amazonaws.com/brightspot/5f/95/cceb14354b458624602dbf42bdd6/reading-holy-bible-767x633.jpg)
![Baker Botts' Biopharma Client Sues Former In-House Attorney, Others Alleging Extortion Scheme Baker Botts' Biopharma Client Sues Former In-House Attorney, Others Alleging Extortion Scheme](https://images.law.com/cdn-cgi/image/format=auto,fit=contain/https://k2-prod-alm.s3.us-east-1.amazonaws.com/brightspot/e4/05/fc4ba7004a53ab9758acacf39d21/pharmaceutical-industry-767x633.jpg)
Baker Botts' Biopharma Client Sues Former In-House Attorney, Others Alleging Extortion Scheme
![People and Purpose: AbbVie's GC on Leading With Impact and Inspiring Change People and Purpose: AbbVie's GC on Leading With Impact and Inspiring Change](https://images.law.com/cdn-cgi/image/format=auto,fit=contain/https://k2-prod-alm.s3.us-east-1.amazonaws.com/brightspot/c4/fa/e3c778cd432c8065001a7cc14139/perry-siatis-767x633.jpg)
People and Purpose: AbbVie's GC on Leading With Impact and Inspiring Change
7 minute readTrending Stories
Who Got The Work
J. Brugh Lower of Gibbons has entered an appearance for industrial equipment supplier Devco Corporation in a pending trademark infringement lawsuit. The suit, accusing the defendant of selling knock-off Graco products, was filed Dec. 18 in New Jersey District Court by Rivkin Radler on behalf of Graco Inc. and Graco Minnesota. The case, assigned to U.S. District Judge Zahid N. Quraishi, is 3:24-cv-11294, Graco Inc. et al v. Devco Corporation.
Who Got The Work
Rebecca Maller-Stein and Kent A. Yalowitz of Arnold & Porter Kaye Scholer have entered their appearances for Hanaco Venture Capital and its executives, Lior Prosor and David Frankel, in a pending securities lawsuit. The action, filed on Dec. 24 in New York Southern District Court by Zell, Aron & Co. on behalf of Goldeneye Advisors, accuses the defendants of negligently and fraudulently managing the plaintiff's $1 million investment. The case, assigned to U.S. District Judge Vernon S. Broderick, is 1:24-cv-09918, Goldeneye Advisors, LLC v. Hanaco Venture Capital, Ltd. et al.
Who Got The Work
Attorneys from A&O Shearman has stepped in as defense counsel for Toronto-Dominion Bank and other defendants in a pending securities class action. The suit, filed Dec. 11 in New York Southern District Court by Bleichmar Fonti & Auld, accuses the defendants of concealing the bank's 'pervasive' deficiencies in regards to its compliance with the Bank Secrecy Act and the quality of its anti-money laundering controls. The case, assigned to U.S. District Judge Arun Subramanian, is 1:24-cv-09445, Gonzalez v. The Toronto-Dominion Bank et al.
Who Got The Work
Crown Castle International, a Pennsylvania company providing shared communications infrastructure, has turned to Luke D. Wolf of Gordon Rees Scully Mansukhani to fend off a pending breach-of-contract lawsuit. The court action, filed Nov. 25 in Michigan Eastern District Court by Hooper Hathaway PC on behalf of The Town Residences LLC, accuses Crown Castle of failing to transfer approximately $30,000 in utility payments from T-Mobile in breach of a roof-top lease and assignment agreement. The case, assigned to U.S. District Judge Susan K. Declercq, is 2:24-cv-13131, The Town Residences LLC v. T-Mobile US, Inc. et al.
Who Got The Work
Wilfred P. Coronato and Daniel M. Schwartz of McCarter & English have stepped in as defense counsel to Electrolux Home Products Inc. in a pending product liability lawsuit. The court action, filed Nov. 26 in New York Eastern District Court by Poulos Lopiccolo PC and Nagel Rice LLP on behalf of David Stern, alleges that the defendant's refrigerators’ drawers and shelving repeatedly break and fall apart within months after purchase. The case, assigned to U.S. District Judge Joan M. Azrack, is 2:24-cv-08204, Stern v. Electrolux Home Products, Inc.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250